Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 1;26(9):611-614.
doi: 10.1093/pm/pnaf045.

Cost disparities between pain and opioid use disorder formulations of buprenorphine in US health care system: a cross-sectional analysis

Robert W Hurley  1   2 , Alexandra M Coffield  3 , Spencer W Faircloth  3 , Jae C Yong  2   4 , Meredith C B Adams  1   2   5
Affiliations

Cost disparities between pain and opioid use disorder formulations of buprenorphine in US health care system: a cross-sectional analysis

Robert W Hurley et al. Pain Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

M.C.B.A.: NIH cooperative grants as listed. NIH grants not related to this work (U01DA057016).

R.W.H: NIH cooperative grants as listed, NIH grants not related to this work (UH3AR077360), Nevro, Inc. for research funds to the institution on the topic of painful diabetic neuropathy and not related to this work, and State Farm for expert/consulting not related to this work.

A.M.C., S.W.F., and J.C.Y. have no potential conflicts to disclose.

Figures

Figure 1:
Figure 1:
Average monthly out-of-pocket patient cost of buprenorphine formulations for pain vs. MOUD treatment across different payment categories.
See this image and copyright information in PMC

References

    1. Chen KY, Chen L, Mao J. Buprenorphine-naloxone therapy in pain management. Anesthesiology. 2014;120(5):1262-1274. 10.1097/ALN.0000000000000170 - DOI - PMC - PubMed
    1. Ballantyne JC. Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain. Pain. Apr. 2015;156(4):567-568. 10.1097/j.pain.0000000000000105 - DOI - PubMed
    1. John WS, Wu LT. Chronic non-cancer pain among adults with substance use disorders: prevalence, characteristics, and association with opioid overdose and healthcare utilization. Drug Alcohol Depend. 2020;209:107902. 10.1016/j.drugalcdep.2020.107902 - DOI - PMC - PubMed
    1. Daitch D, Daitch J, Novinson D, Frey M, Mitnick C, Pergolizzi J. Jr Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients. Pain Med. 2014;15(12):2087-2094. 10.1111/pme.12520 - DOI - PubMed
    1. Thompson MG, Kuriyama A, Yoshino T, Murphy MG, Jackson JL. Buprenorphine Use in the United States, 2010-2019. Am J Med. 2024;137(3):280-283. 10.1016/j.amjmed.2023.11.004 - DOI - PubMed